Rescuing Dicer expression in inflamed colon tissues alleviates colitis and prevents colitis-associated tumorigenesis

Theranostics. 2020 Apr 27;10(13):5749-5762. doi: 10.7150/thno.41894. eCollection 2020.

Abstract

Chronic inflammation is known to promote carcinogenesis; Dicer heterozygous mice are more likely to develop colitis-associated tumors. This study investigates whether Dicer is downregulated in inflamed colon tissues before malignancy occurs and whether increasing Dicer expression in inflamed colon tissues can alleviate colitis and prevent colitis-associated tumorigenesis. Methods: Gene expression in colon tissues was analyzed by immunohistochemistry, immunoblots, and real-time RT-PCR. Hydrogen peroxide or N-acetyl-L-cysteine was used to induce or alleviate oxidative stress, respectively. Mice were given azoxymethane followed by dextran sulfate sodium to induce colitis and colon tumors. Berberine, anastrozole, or pranoprofen was used to rescue Dicer expression in inflammatory colon tissues. Results: Oxidative stress repressed Dicer expression in inflamed colon tissues by inducing miR-215 expression. Decreased Dicer expression increased DNA damage and cytosolic DNA and promoted interleukin-6 expression upon hydrogen peroxide treatment. Dicer overexpression in inflamed colon tissues alleviated inflammation and repressed colitis-associated carcinogenesis. Furthermore, we found that anastrozole, berberine, and pranoprofen could promote Dicer expression and protect cells from hydrogen peroxide-induced DNA damage, thereby reducing cytosolic DNA and partially repressing interleukin-6 expression upon hydrogen peroxide treatment. Rescuing Dicer expression using anastrozole, berberine, or pranoprofen in inflamed colon tissues alleviated colitis and prevented colitis-associated tumorigenesis. Conclusions: Dicer was downregulated in inflamed colon tissues before malignancy occurred. Decreased Dicer expression further exaggerated inflammation, which may promote carcinogenesis. Anastrozole, berberine, and pranoprofen alleviated colitis and colitis-associated tumorigenesis by promoting Dicer expression. Our study provides insight into potential colitis treatment and colitis-associated colon cancer prevention strategies.

Keywords: Dicer; anastrozole; berberine; colitis-associated carcinogenesis; pranoprofen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anastrozole / pharmacology
  • Animals
  • Berberine / pharmacology
  • Carcinogenesis / genetics
  • Carcinogenesis / metabolism
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic / genetics
  • Colitis / metabolism
  • Colon / metabolism
  • Colon / pathology*
  • DEAD-box RNA Helicases / genetics*
  • DEAD-box RNA Helicases / metabolism*
  • Gene Expression / genetics
  • Gene Expression Regulation / genetics
  • Humans
  • Inflammation / genetics
  • Intestinal Mucosa / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Oxidative Stress / physiology
  • Ribonuclease III / genetics*
  • Ribonuclease III / metabolism*
  • Signal Transduction / drug effects

Substances

  • MIRN215 microRNA, mouse
  • MicroRNAs
  • Berberine
  • Anastrozole
  • DICER1 protein, human
  • Dicer1 protein, mouse
  • Ribonuclease III
  • DEAD-box RNA Helicases